To provide a more meaningful assertion that EEP treatment could foster an increased differentiated GC subtype susceptibility, we utilized a spontaneous disease animal model of GC (A4gnt KO mice) that uniquely recapitulates a well-developed differentiated-type gastric adenocarcinoma at around 60-weeks of age. The gene discussed is A4GNT; the disease is gastric cancer.